This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEB2C0AG_M.jpg
The net loss for Q4 was reported at $180 million, marking a significant improvement from last year’s loss of $415 million. Meanwhile, Walgreens’ quarterly sales saw a year-over-year increase of 9.2%, reaching $35.422 billion and surpassing the consensus estimate of $34.78 billion. According to InvestingPro data, the company’s revenue for the last twelve months stood at a staggering $136.11B USD, with a growth rate of 1.18%.
Looking forward to the next fiscal year, Walgreens has projected sales between $141 billion and $145 billion, along with an adjusted EPS in the range of $3.20 to $3.50. As of Thursday, WBA shares were trading at $23.66, within a one-year range of $20.58 – $42.29. The InvestingPro Fair Value for the company is currently set at $24.66 USD, indicating a potential upside for investors.
Analysts forecast that the company’s annual earnings and revenue will reach approximately $3.72 per share and $144.24 billion respectively, indicating a positive outlook for Walgreens in the upcoming fiscal year despite the recent shortfall in earnings. Yet, it’s worth noting from InvestingPro Tips that 4 analysts have revised their earnings downwards for the upcoming period.
Despite the recent financial hiccups, Walgreens has a strong history of rewarding its shareholders. It has raised its dividend for 47 consecutive years and pays a significant dividend to shareholders, with a current yield of 8.5% according to InvestingPro data. This consistent performance in dividend payments makes it an attractive option for income-focused investors.
For more insights like these, interested investors can explore the InvestingPro platform where they’ll find numerous additional tips and real-time metrics on a vast array of companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
